Immunic Inc.
(IMUX)
undefined
undefined%
At close: undefined
1.15
1.77%
After-hours Dec 13, 2024, 06:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | - | - | - | - | - | - | - | 6.32K | - | - | - | - | - |
Cost of Revenue | 111.00K | 77.00K | 85.00K | 39.00K | 50.00K | 15.00K | 998.00K | 1.81M | 1.33M | - | - | - | - |
Gross Profit | -111.00K | -77.00K | -85.00K | -39.00K | -50.00K | -15.00K | -998.00K | -1.80M | -1.33M | - | - | - | - |
Operating Income | -99.22M | -119.49M | -91.67M | -48.97M | -37.03M | -42.02M | -52.66M | -41.27M | -52.12M | -50.34M | -31.40M | -9.58M | -8.58M |
Interest Income | 3.08M | 1.04M | 66.00K | 58.00K | 107.00K | 521.00K | 650.00K | 284.00K | 58.00K | 19.00K | 5.00K | 4.00K | 2.00K |
Pretax Income | -93.61M | -120.41M | -92.94M | -44.02M | -34.93M | -41.48M | -52.08M | -40.97M | -52.02M | -47.67M | -32.72M | -6.70M | -5.88M |
Net Income | -93.61M | -154.30M | -92.79M | -43.96M | -34.83M | -41.48M | -52.08M | -40.97M | -52.02M | -47.67M | -32.72M | -6.70M | -5.88M |
Selling & General & Admin | 16.01M | 15.26M | 13.30M | 10.33M | 14.52M | 13.59M | 13.31M | 11.22M | 12.35M | 10.86M | 9.62M | 4.48M | 3.07M |
Research & Development | 83.22M | 71.25M | 61.12M | 38.64M | 22.51M | 24.82M | 39.34M | 30.05M | 39.77M | 39.48M | 21.79M | 5.10M | 5.51M |
Other Expenses | - | -1.96M | 17.25M | 4.90M | 1.99M | 28.00K | - | 297.00K | 97.00K | 2.67M | - | - | - |
Operating Expenses | 99.22M | 86.52M | 91.67M | 48.97M | 37.03M | 38.41M | 52.66M | 41.27M | 52.12M | 50.34M | 31.40M | 9.58M | 8.58M |
Interest Expense | - | 1.04M | - | - | 107.00K | - | - | - | - | - | - | 413.00K | 9.25M |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 99.22M | 86.52M | 91.67M | 48.97M | 37.03M | 38.41M | 52.66M | 41.27M | 52.12M | 50.34M | 31.40M | 9.58M | 8.58M |
Income Tax | - | 33.89M | -151.00K | -58.00K | -107.00K | 549.00K | -577.00K | -1.81M | -1.33M | -1.09M | - | 413.00K | 9.25M |
Shares Outstanding (Basic) | 44.32M | 31.82M | 23.65M | 15.66M | 7.72M | 1.06M | 996.48K | 784.69K | 628.82K | 595.78K | 14.10K | 14.10K | 14.10K |
Shares Outstanding (Diluted) | 44.32M | 31.82M | 23.65M | 15.66M | 7.72M | 1.06M | 996.48K | 784.69K | 628.82K | 595.78K | 14.10K | 14.10K | 14.10K |
EPS (Basic) | -2.11 | -4.85 | -3.92 | -2.81 | -4.51 | -39.16 | -52.26 | -52.21 | -82.73 | -80.01 | -2.32K | -475.11 | -416.83 |
EPS (Diluted) | -2.11 | -4.85 | -3.92 | -2.81 | -4.51 | -39.16 | -52.26 | -52.21 | -82.73 | -80.01 | -2.32K | -475.11 | -416.83 |
EBITDA | -99.11M | -120.33M | -92.86M | -48.93M | -36.98M | -15.14M | -51.08M | -39.16M | -50.70M | -46.58M | -31.92M | -5.64M | -7.62M |
Depreciation & Amortization | 111.00K | 77.00K | 85.00K | 39.00K | 50.00K | 15.00K | 998.00K | 1.81M | 1.33M | 1.09M | 799.00K | 651.00K | 961.00K |